Enzymatica focuses on product development based on the tested and patented barrier technology used in the cold product ColdZyme. Strengthening the clinical documentation for ColdZyme is a key part of Enzymatica’s R&D activities.
Over the next few years the company aims to expand the range of enzyme-based products. An example of this is the new flavor Strawberry, which was launched in 2019. The new flavor is attractive for both younger and older consumers. In 2019 a new mouth spray was developed, which is registered under the EU Cosmetic regulation, for the German market addressing oral health. In the longer term, the intention is to develop products for other indications.
In 2020, development efforts focused on recertification of ColdZyme® to class III according to the MDD, as well as formulating the necessary documentation and packaging design for the introduction on new markets. The work on additional product variants (line extensions) also continued.